PRLR and neoplasm: A recent study demonstrated that PRLR-SF reduces nucleotide synthesis by inhibiting the pentose phosphate pathway (PPP) through the NEK9-Hippo pathway in PDAC cells and in xenografted tumors in mice, hindering proliferation and tumor growth.